Clinical trial
D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism
NCT00264277 · IRCCS Azienda Ospedaliero-Universitaria di Bologna, Other · Completed
Key facts
| NCT number | NCT00264277 |
|---|---|
| Title | D-dimer to Establish Duration of Anticoagulation After Venous Thromboembolism |
| Official title | D-dimer Test to Establish Duration of Anticoagulation After a First Idiopathic Episode of Venous Thromboembolism; the Prospective Randomized "Prolong" Study |
| Lead sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Vitamin K antagonist (Coumarin anticoagulants) |
| Enrollment | 600 |
| Start date | Sep 1, 2002 |
| Primary completion | Dec 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Dec 12, 2005 |
| Last update posted | Mar 19, 2021 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: